1927 nm Diode Laser for Infraorbital Hyperpigmentation in Skin of Color: Safe and Effective Approach

July 2026 | Volume 25 | Issue 7 | 666 | Copyright © July 2026


Published online June 29, 2026

Leslie M. Garza-García MDa, Payvand Kamrani DOb, Maya Firsowicz MDb, Sabrina G. Fabi MDb

aDepartment of Dermatology, University Hospital Dr. José E. González, Universidad Autónoma de Nuevo León, Monterrey, Mexico
bCosmetic Laser Dermatology, San Diego, CA

Abstract
Background: Infraorbital hyperpigmentation (IOH) is a common aesthetic concern with multifactorial pathogenesis, especially prevalent in patients with skin of color (SOC). Its management remains challenging due to the delicate anatomy of the periorbital area and the increased risk of post-inflammatory hyperpigmentation associated with many energy-based treatments.
Objective: To evaluate the clinical efficacy and safety of a 1927 nm non-ablative fractional diode laser in the treatment of IOH in patients with SOC.
Methods: We present a case series of 4 female patients with Fitzpatrick skin types III to IV and clinical diagnoses of IOH. All patients were treated at a single dermatologic practice using the 1927 nm Clear + Brilliant Permea® laser. Each patient received eight non-ablative fractional passes at a high treatment level. Most patients did not receive additional topical therapies. Clinical outcomes are evaluated based on physician observation and patient-reported satisfaction.
Results: All patients demonstrated progressive improvement in periorbital pigmentation, increased brightness, and enhanced skin texture. Results were noticeable within weeks of treatment and were maintained over time. No adverse effects, including post-inflammatory hyperpigmentation, were observed.
Conclusion: The 1927 nm diode laser appears to be a safe and effective option for the treatment of infraorbital hyperpigmentation in patients with SOC. Its favorable safety profile and gradual clinical improvement make it a promising tool for addressing pigmentary and structural components of IOH. Further controlled studies are needed to validate these findings.

 

INTRODUCTION

Infraorbital hyperpigmentation (IOH), commonly referred to as "dark circles," is a prevalent and distressing cosmetic concern. Infraorbital hyperpigmentation is often societally associated with fatigue, stress, or sadness, and can be perceived as a visible marker of physical exhaustion and premature aging. These associations can consequently impact self-perception and quality of life for affected patients.

IOH can be observed across all ethnicities, sexes, and ages; however, its prevalence and severity are notably higher in females and skin of color (SOC).1 The pathogenesis of IOH is complex and multifactorial, with several contributing intrinsic and extrinsic factors that interact in diverse ways. This condition is particularly challenging to treat due to its various presentations and underlying causes, which can often coexist within the same patient.

To facilitate diagnosis and guide treatment approaches, IOH has been classified in the literature into 4 subtypes: vascular, structural, pigmented, and mixed.1 However, it is important to highlight that external factors such as environmental exposure and lifestyle habits significantly contribute to the onset and exacerbation of IOH, regardless of the primary subtype. External lifestyle factors such as inadequate sleep, psychological stress, and frequent eye rubbing can aggravate both pigmentary and vascular components of IOH by disturbing skin homeostasis.7 Proposed mechanisms include activation of the hypothalamic-pituitary-adrenal (HPA) axis and stimulation of melanin production.6 Recognizing these influences is essential for accurate assessment and individualized treatment planning.

In this review, we will cover classifications and etiologies of infraorbital pigmentation, differential diagnosis, and highlight treatment modalities. We will also present a case series demonstrating significant improvement in infraorbital hyperpigmentation among patients treated with the 1927 nm diode laser, with no adverse events reported.

Classification
Pigmented
Pigmentary IOH is primarily due to excessive melanin deposition in the infraorbital region. It may be constitutional, often with a familial predisposition, or acquired through post-inflammatory